Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1401449	艾曲泊帕片	eltrombopag olamine	Tablet	Chemical Drugs(3.1)	New Drug Application	2014-10-30	中美华世通生物医药科技（武汉）有限公司	Waterstone Pharmaceuticals (WUHAN) Co Ltd	Certificate Issued	2016-03-28	view
CXHL1401447	艾曲泊帕	eltrombopag olamine	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2014-10-30	中美华世通生物医药科技（武汉）有限公司	Waterstone Pharmaceuticals (WUHAN) Co Ltd	Certificate Issued	2016-03-28	view
CXHL1401450	艾曲泊帕片	eltrombopag olamine	Tablet	Chemical Drugs(3.1)	New Drug Application	2014-10-30	中美华世通生物医药科技（武汉）有限公司	Waterstone Pharmaceuticals (WUHAN) Co Ltd	Certificate Issued	2016-03-28	view
CXHL1401448	艾曲泊帕片	eltrombopag olamine	Tablet	Chemical Drugs(3.1)	New Drug Application	2014-10-30	中美华世通生物医药科技（武汉）有限公司	Waterstone Pharmaceuticals (WUHAN) Co Ltd	Certificate Issued	2016-03-28	view
CXHL1401904	右旋兰索拉唑	dexlansoprazole	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2015-02-13	中美华世通生物医药科技（武汉）有限公司	Waterstone Pharmaceuticals (WUHAN) Co Ltd	Certificate Issued	2016-05-19	view